Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ijpharm.2007.01.045
DC FieldValue
dc.titleDSC and EPR investigations on effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within lipid bilayer membrane
dc.contributor.authorZhao, L.
dc.contributor.authorFeng, S.-S.
dc.contributor.authorKocherginsky, N.
dc.contributor.authorKostetski, I.
dc.date.accessioned2014-06-17T07:39:06Z
dc.date.available2014-06-17T07:39:06Z
dc.date.issued2007-06-29
dc.identifier.citationZhao, L., Feng, S.-S., Kocherginsky, N., Kostetski, I. (2007-06-29). DSC and EPR investigations on effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within lipid bilayer membrane. International Journal of Pharmaceutics 338 (1-2) : 258-266. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ijpharm.2007.01.045
dc.identifier.issn03785173
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/63752
dc.description.abstractDifferential scanning calorimetry (DSC) and electron paramagnetic resonance spectroscopy (EPR) were applied to investigate effects of cholesterol component on molecular interactions between paclitaxel, which is one of the best antineoplastic agents found from nature, and dipalmitoylphosphatidylcholine (DPPC) within lipid bilayer vesicles (liposomes), which could also be used as a model cell membrane. DSC analysis showed that incorporation of paclitaxel into the DPPC bilayer causes a reduction in the cooperativity of bilayer phase transition, leading to a looser and more flexible bilayer structure. Including cholesterol component in the DPPC/paclitaxel mixed bilayer can facilitate the molecular interaction between paclitaxel and lipid and make the tertiary system more stable. EPR analysis demonstrated that both of paclitaxel and cholesterol have fluidization effect on the DPPC bilayer membranes although cholesterol has more significant effect than paclitaxel does. The reduction kinetics of nitroxides by ascorbic acid showed that paclitaxel can inhibit the reaction by blocking the diffusion of either the ascorbic acid or nitroxide molecules since the reaction is tested to be a first order one. Cholesterol can remarkably increase the reduction reaction speed. This research may provide useful information for optimizing liposomal formulation of the drug as well as for understanding the pharmacology of paclitaxel. © 2007 Elsevier B.V. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.ijpharm.2007.01.045
dc.sourceScopus
dc.subjectAnticancer drugs
dc.subjectDifferential scanning calorimetry (DSC)
dc.subjectElectron paramagnetic resonance spectroscopy (EPR)
dc.subjectLiposomes
dc.subjectNanomedicine
dc.subjectTaxol®
dc.typeArticle
dc.contributor.departmentCHEMICAL & BIOMOLECULAR ENGINEERING
dc.contributor.departmentBIOENGINEERING
dc.description.doi10.1016/j.ijpharm.2007.01.045
dc.description.sourcetitleInternational Journal of Pharmaceutics
dc.description.volume338
dc.description.issue1-2
dc.description.page258-266
dc.description.codenIJPHD
dc.identifier.isiut000247494600035
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.